| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6159436 | The Journal of Urology | 2012 | 6 Pages |
Abstract
This randomized trial with median followup approaching 9 years showed that cryoablation was inferior in attaining biochemical disease-free survival in patients with locally advanced prostate cancer (cT2c-T3). Cryoablation may be more suited for less bulky prostate cancer. Longer duration neoadjuvant hormonal therapy or a multimodal approach may provide optimal biochemical disease-free survival in this patient population.
Keywords
bDFSPSADSSLHRHCryosurgeryEBRTTRUSProstate specific antigenDisease specific survivalbiochemical disease-free survivaloverall survivalcomputerized tomographyRadiotherapyProstate cancerTransrectal ultrasoundProstatic neoplasmsluteinizing hormone-releasing hormoneHormonal therapyExternal beam radiotherapyCryoablationCryoCaP
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Joseph L. Chin, Ali A. Al-Zahrani, Ana Maria Autran-Gomez, Andrew K. Williams, Glenn Bauman,